FindTrial
Sign In

Comparative efficacy of topical phenytoin and human placental extract in wound healing

A Comparative study on efficacy of topical phenytoin versus human placental extract in wound healing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101835
Enrollment
60
Registered
2026-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L979- Non-pressure chronic ulcer of unspecified part of lower leg

Interventions

Intervention1: Phenytoin versus Human placental extract: Topical application of injection phenytoin 100mg diluted with 10ml normal saline and wound dressing Intervention2: Nil: Nil Control Interventio

Sponsors

Vignesh kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: wound size between 1 to 50 cm2

Exclusion criteria

Exclusion criteria: Allergic to phenytoin or human placental extract Immunocompromised status Wound with malignancy Severe comorbidities Non ambulatory patients

Design outcomes

Primary

MeasureTime frame
if proven superior human placental extract could be integrated into standard wound care protocolTimepoint: daily dressings for four weeks - wound size reduction and granulation tissue formation—

Secondary

MeasureTime frame
nilTimepoint: nil;Timepoint:—

Countries

India

Contacts

Public ContactVignesh kumar

Trichy SRM Medical college hospital and research centre

vignesh007bharathi@gmail.com09944182222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026